Abstract
Evidence suggests latent cytomegalovirus (CMV) infection may increase risk of chronic disease in HIV-infected persons on anti-retroviral therapy (ART). This work explored CMV-specific antibodies (IE-1, gB and lysate ant1gens) as a biomarker for cardiovascular disease, neurocognitive impairment or insulin resistance in Australian HIV cohorts. Levels of autoantibody, total antibody and inflammatory markers were characterised in longitudinal and cross-sectional studies. A novel association between cytomegalovirus antibody and insulin resistance was found, independent of CD4 T-cell depletion, total antibody level and ageing. The findings suggest elevated CMV antibody levels may be indicative of developing insulin resistance in HIV patients on ART.
Original language | English |
---|---|
Qualification | Masters |
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 16 Aug 2016 |
Publication status | Unpublished - 2016 |